Curriculum vitae

 

Prof. Dr. Martin Schulz, FFIP, FESCP

Curriculum Vitae

October 2024

 

PERSONAL INFORMATION

Home address:                                                                                   
Der Werder 8                                                                                 
14774 Brandenburg an der Havel                                                                                   
Germany                                                                                            

     

EDUCATION AND TRAINING

 

Institution	Dates of Attendance	Major Field of Study	Degree	Date
University of Hamburg	1978 – 1982	Study of Pharmacy	BS in Pharmacy	April 1982
University of Hamburg	1984 – 1986	Study of Medicine

 

 

DOCTORAL DISSERTATION

Dr. rer. nat. (PhD) in Pharmacology, University of Hamburg, August 1988, titled
"Interactions of selected histamine H2-receptor antagonists with the cytochrome P-450 system and potential effects on the
pharmacokinetics of non-steroidal anti-inflammatory drugs."

PROFESSIONAL EXPERIENCE 

 

Name and Location of Institution	Rank or Position	Dates of Service
Community Pharmacy (Apotheke am Muemmelmannsberg), Hamburg	Pharmacy Intern	May – October 1982
University of Hamburg, University Medical Center Eppendorf, Institute of Pharmacology	Pharmacy Intern (Graduate Student)	November 1982 – April 1983
Hospital St. Adolf-Stift, Department of Pharmacy, Reinbek	Clinical Pharmacist	June 1983 – September 1984
University of Hamburg, University Medical Center, Institute of Pharmacology and Institute of Legal Medicine	PhD-student	October 1984 – September 1988
ABDA – Federal Union of German Associations of Pharmacists, Frankfurt/M., Eschborn, Berlin	Head, Center for Drug Information and Pharmacy Practice (ZAPP)	October 1988 – 2008
German Institute for Drug Use Evaluation (DAPI), Berlin	Director Pharmacy	2002 – present
Goethe-University Frankfurt, Department of Pharmacology	Adjunct Professor	2005 – present
ABDA – Federal Union of German Associations of Pharmacists, Berlin	Department of Medicine, Director	2008 – present
Drug Commission of German Pharmacists (AMK), Berlin	Chairman	2009 – present
Freie Universität Berlin, Institute of Pharmacy	Adjunct Professor	2019 – present

 

 
LICENCES

German "Approbation"                                                                                 May 1983
Licence as pharmacist (RPh), State of Hamburg
Expert/Board Certified in Pharmacology                                                  July 1989
German Society for Experimental and Clinical Pharmacology and Toxicology
Drug Information Pharmacist/Specialist                                                  July 1993
Chamber of Pharmacists Hesse, Frankfurt at Main, Germany                                                                              

AWARDS AND HONORS

Best Poster Award                                                                                       2022
8^th PCNE Working Symposium

André Bédat Award                                                                                     2020
FIP’s highest pharmaceutical practice award, awarded every three years
[Dtsch. Ärztebl. 2020; 117 (47): A 2303/B 1943].
Adjunct Fellow (Honorary) University of Technology Sydney (UTS)           2020–2026
Graduate School of Health
Best Publication Prize (1^st prize)                                                                2020
Chronic Heart Failure Working Group, German Cardiac Society (DGK)
[Pharm. Ztg. 2020; 165 (43): 2971.  Newsroom    DGK,
Cardio News 2020; 23 (11/12): 42–43]   
Associate University of Technology Sydney (UTS)                                       2017–2020
Graduate School of Health
Best Poster Award                                                                                       2017
46^th Symposium, European Society of Clinical Pharmacy (ESCP)
Honorary Member                                                                                      2017
Pharmaceutical Care Network Europe (PCNE)
Poster Award                                                                                                2016
FIP Community Pharmacy Section
Fellow of the ESCP (FESCP)                                                                     2013
European Society of Clinical Pharmacy (ESCP)
Lesmueller-Lecture                                                                                     2013
Lesmueller Foundation, Munich
Distinguished Practice Award                                                                    2013
International Pharmaceutical Federation (FIP)
Best Poster Award                                                                                       2011
7^th Pharmaceutical Care Network Europe (PCNE) Working Conference
Fellow of the FIP (FFIP)                                                                            2009
International Pharmaceutical Federation (FIP)

Poster Award                                                                                                2009
Community Pharmacy Section, FIP
Best Poster Award                                                                                       2008
33^rd Scientific Congress, German Society of Hospital Pharmacists (ADKA)
IMS Health and FIP Prize                                                                          2005
International Pharmaceutical Federation (FIP)
Health Base Foundation Award                                                                 1999
European Society of Clinical Pharmacy (ESCP)

PROFESSIONAL ORGANIZATIONS (MEMBER) 

 

1.       German Society for Experimental and Clinical Pharmacology and Toxicology (DGPT)

2.       German Pharmaceutical Society (DPhG)

3.       German Society of Toxicological and Forensic Chemistry (GTFCh)

4.       International Pharmaceutical Federation (FIP)

5.       American College of Clinical Pharmacy (ACCP)

6.       European Society of Clinical Pharmacy (ESCP)

7.       German Network Evidence-based Medicine (DNEbM)

8.     German Diabetes Society (DDG)

9.      International Society for Pharmacoepidemiology (ISPE)

10.    German Cardiac Society (DGK) /  European Society of Cardiology (ESC)

11.    Cochrane Collaboration

12.    Heart Failure Association (HFA) of the ESC 

13.   American Pharmacists Association (APhA) 

14.   American Heart Association (AHA) 

 

PROFESSIONAL SERVICES, COMMITTEE MEMBERSHIPS AND OTHER ACTIVITIES

 

ACCP/ESCP-Conferences on Clinical Pharmacy, Member, Scientific Committees 
Berlin, DE (1999), Amsterdam, NL (2005), Orlando, FL, USA (2009), and Heidelberg, DE (2017).

 

Action Plan for Medication Safety (AMTS) in Germany of the Federal Ministry of Health (BMG); 
Member Managing Committee, 2008 – present. 

CARE-HK in HF registry  
Co-National Lead Germany, 2021 – present. 

Member Congress Advisory Board 2^nd Global Patient Safety Action Summit 2017.
Bonn, 29–30 March 2017 (Federal Ministry of Health).

Dr. Hellmuth-Haeussermann Foundation / Award: Member Jury (Board of Trustees), 2006 – 2020.

Editorial/Scientific Boards
Frontiers in Pharmacology – Associate Editor Drugs Outcomes Research and Policies specialty section, 2021 – present.
Journal of Research in Pharmacy Practice, 2011 – present.
Pharmacy Practice, 2006 – present. 

Pharmacoepidemiology and Drug Safety, 2017 – 2023.
Annals of Pharmacotherapy, 2003 – 2013.
DRUGDEX®; Micromedex, Inc., 1998 – 2010.
Pharmazeutische Zeitung Wissenschaft (Pharmaceutical Journal – Scientific Edition), 1989 – 1993. 

European Society of Clinical Pharmacy (ESCP)
Member of the Board (General Committee), 2006 – 2012;  Member of the Research Committee, 2006 – 2017.

Federal Chamber of Pharmacists (BAK)
Member Expert Committees Post-graduate Specialization: Drug Information (2002 – present) and Toxicology (2002 – 2020).

Federal Institute for Drugs and Medical Devices (BfArM), voting member
- Commission/Expert Advisory Committee on Prescription-only Drugs
  (Sachverständigenausschuss für Verschreibungspflicht), 2009 – present.
- Commission/Expert Advisory Committee on Pharmacy-only Drugs
  (Sachverständigenausschuss für Apothekenpflicht), 1989 – present.
- Committee on Pharmacology at the Commission for the German Pharmacopeia
  (Ausschuss für Pharmakologie der Deutschen Arzneibuch-Kommission), 2000 –  present.  

- Commission on Processing Drugs in Neurology/Psychiatry
  (Aufbereitungskommission B3), 1989 – 1995.

 
Advisory Council on Drug Shortages Section 52b (3b) Medicinal Products Act (AMG; BMG/BfArM), Member. 
Federal Ministry of Health (BMG), Member high-level working group pediatric drug shortages, 9/2023 – 4/2024. 

German Diabetes Society (DDG) - Founding member (2000) and Vice-Chair (– present) of the DDG/Federal Chamber
of Pharmacists’ (BAK) Joint Commission on the Role and Involvement of Pharmacists in the Care of Diabetic Patients. 
Committee Member, Pharmacotherapy of Diabetes (2016 – present). 

GKV-Arzneimittelindex (Statutory Health Insurance Drug Index)
Member Advisory Board, 2009 – present.

Clinical Practice Guideline Committees – voting member

·         National Disease Management/Clinical Practice Guidelines (Nationale VersorgungsLeitlinien [NVL])

·         Asthma, 2008 – present 

·         Chronic Heart Failure, 2017 – present 

·         COPD, 2020 – present 

·         Diabetes, 2020 – present  

·         S3 Guidelines: Drug-related disorders, 2021–2022; Atrial fibrillation, 2023 – present. 

Institute for Quality and Efficiency in Health Care (IQWiG), Member Board of Trustees (HTA), 2008 – present.

International Pharmaceutical Federation (FIP)
Planning Committee Continuing Education Programme/Continuing Professional Development of the Community Pharmacy Section (CPS), 1993 – 2007;
Board of Pharmaceutical Practice (BPP): Expert Member (2006 – 2013), Member Programme Committee (2002 – 2006), and Chairman Programme Committee (2006 – 2011); Co-Chair FIP Centennial Programme Committee (2010 – 2012); Board of Pharmaceutical Sciences (BPS): Vice-chair SIG Pharmacy Practice Research (2016 – 2019); Member BPP Selection Committee Practice Awards (2022 – present).

Peer Reviewer for (~ in the order of IF): BMJ, Nature Reviews Cardiology, European Heart Journal, European Journal of Heart Failure, Journal of Internal Medicine, Thorax, Cochrane Database of Systematic Reviews, Clinical Pharmacology & Therapeutics, Clinical Research in Cardiology, Journal of the American Heart Association, Frontiers in Pharmacology, American Journal of Preventive Medicine, Pharmacotherapy, ESC Heart Failure, Preventive Medicine, British Journal of Clinical Pharmacology, Toxicology, International Journal of Chronic Obstructive Pulmonary Disease, Drug Safety, Drug Design, Development and Therapy, International Journal of Cardiology, PLoS ONE, Cardiovascular Drugs and Therapy, Journal of Clinical Hypertension, American Journal of Cardiovascular Drugs, Research in Social and Administrative Pharmacy, BMJ Open, Annals of Pharmacotherapy, Journal of Clinical Pharmacology, Kardiologia Polska, Journal of Human Hypertension, European Journal of Clinical Pharmacology, Pharmacoepidemiology and Drug Safety, Clinical Interventions in Aging, European Journal of Health Economics, Health Policy, Pharmacopsychiatry, International Journal for Quality in Health Care, Patient Preference and Adherence, International Journal of General Medicine, Journal of Multidisciplinary Healthcare, Journal of Health Services Research & Policy, International Journal of Behavioral Medicine, BMC Family Practice, International Journal of Clinical Pharmacy, Journal of the American Pharmaceutical Association, Die PHARMAZIE, European Journal of Hospital Pharmacy, Das Gesundheitswesen, Journal of Integrated Pharmacy Research and Practice, ClinicoEconomics and Outcomes Research, International Journal of Pharmacy Practice, Current Drug Safety, Journal of Pharmacy Technology, and GaBI Journal.  

Pharmaceutical Care Foundation (FI) 
Member Scientific Board; 1998 – 2006 and 2011 – present.

Pharmaceutical Care Network Europe (PCNE)
Founding member, 1994; Chairman, 1999 – 2001; Member of the Board, 1999 – 2005; Honorary Member, 2017.

Task Force "Lunapharm", Ministry of Health, Federal State of Brandenburg; Member, 2018.

 

 

PUBLICATIONS

Over 500 articles (full lists); h-index: 33; citations >6,400; i10-index: 78; Research Interest Score: 3,048. 
Listed in “World’s Top 2% Scientists Ranking", published by Stanford University, v7, August 2024. 
 

List of selected publications

1.         Schulz, M. and Schmoldt, A.: 
INTERACTIONS OF THE HISTAMINE H₂-RECEPTOR ANTAGONIST ETINTIDINE WITH RAT
LIVER CYTOCHROME P-450: A COMPARISON WITH CIMETIDINE. 
Naunyn-Schmiedeberg's Arch. Pharmacol. 1987; 336 (4): 453–458. 
PubMed  

 2.        Frese, J.H., Rohland, L., Schulz, M. and Schmoldt, A.: 
INTOXIKATION MIT GALLOPAMIL. Verlauf und Therapie
[Gallopamil poisoning. Its course and therapy]. 
Dtsch. Med. Wochenschr. 1998; 113 (19): 770–772. 
PubMed

 3.        Schulz, M.: 
INTERAKTIONEN AUSGEWÄHLTER HISTAMIN H₂-REZEPTORANTAGONISTEN MIT DEM 
CYTOCHROM P-450-SYSTEM UND MÖGLICHE AUSWIRKUNGEN AUF DIE PHARMAKO-
KINETIK NICHTSTEROIDALER ANTIRHEUMATIKA
[Interactions of selected histamine H2-receptor antagonists with the cytochrome P-450 system and potential
effects on the pharmacokinetics of non-steroidal antiinflammatory drugs].
Dissertation Dr. rer. nat. (PhD thesis), University of Hamburg 1988. 

 4.        Schulz, M., Schmoldt, A., Donn, F. and Becker, H.: 
THE PHARMACOKINETICS OF FLUTAMIDE AND ITS MAJOR METABOLITES AFTER A SINGLE ORAL DOSE
AND DURING CHRONIC TREATMENT. 
Eur. J. Clin. Pharmacol. 1988; 34 (6): 633–636. 
PubMed

 5.        Schulz, M. and Schmoldt, A.: 
ON THE SULPHOXIDATION OF CIMETIDINE AND ETINTIDINE BY RAT AND HUMAN LIVER MICROSOMES. 
Xenobiotica. 1988; 18 (8): 983–989. 
PubMed

 6.        Donn, F., Bruns, T., von Meyerinck, L., Schulz, M., Becker, W.-M., Becker, H. and
Klosterhalfen, H.:
MONOCLONAL ANTIBODY THAT DEFINES THE PROSTATE SPECIFIC ANTIGEN.
Prostate. 1989; 14 (3): 237–249.
PubMed

 7.        Schulz, M. and Schmoldt, A.:
DETERMINATION OF NONSTEROIDAL ANTI-INFLAMMATORY DRUGS IN HUMAN PLASMA
BY HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY.
Pharm. Ztg. Wiss. 1989; 134 (2): 41–44.

 8.        Schulz, M., Wischhusen, F. and Schmoldt, A.:
THERAPEUTISCHE UND TOXISCHE PLASMAKONZENTRATIONEN SOWIE ELIMINATIONSHALBWERTSZEITEN GEBRÄUCHLICHER ARZNEISTOFFE.
Anästhesiol. Intensivmed. Notfallmed. Schmerzther. 1991; 26 (1): 37–43.
PubMed 

            Schulz, M. and Schmoldt, A.:
as extended version in: Pharm. Ztg. Wiss. 1991; 136 (4): 87–94.

 9.        Schulz, M. and Schmoldt, A.:
KONZENTRATIONEN VON CEFOTIAM IM KOLONGEWEBE UND PLASMA NACH APPLIKATION ZUR PERIOPERATIVEN ANTIBIOTIKA-PROPHYLAXE
[Concentrations of cefotiam in colon tissue and plasma after application for perioperative antibiotic prophylaxis].
Zeitschr. Antimikrobiol. Antineoplast. Chemother. 1992; 10: 33–37.

10.       Schulz, M. and Schmoldt, A.:
NON-INTERACTION OF RANITIDINE WITH HYDROXYLATION OF DICLOFENAC IN RAT AND
HUMAN LIVER MICROSOMES.
Pharmazie. 1993; 48 (8): 625–626.
PubMed

11.       Schulz, M. and Schmoldt, A.:
SUCCESSFUL PHYSOSTIGMINE TREATMENT OF ACUTE DOTHIEPIN INTOXICATION.
Pharmazie. 1994; 49 (8): 614.
PubMed

12.       Scholz, J., Bause, H., Schulz, M., Klotz, U., Krishna, D.R., Pohl, S. and Schulte am Esch, J.:
PHARMACOKINETICS AND EFFECTS ON INTRACRANIAL PRESSURE OF SUFENTANIL IN HEAD TRAUMA PATIENTS.
Br. J. Clin. Pharmacol. 1994; 38 (4): 369–372.
PubMed

13.       Schulz, M. and Schmoldt, A.:
ZUSAMMENSTELLUNG THERAPEUTISCHER UND TOXISCHER PLASMAKONZENTRATIONSBEREICHE
VON ARZNEISTOFFEN.
Anaesthesist. 1994; 43 (12): 835–844.
PubMed

14.       Scholz, J., Schulz, M., Steinfath, M., Höver, S. and Bause, H.:
FLUCONAZOLE IS REMOVED BY CONTINUOUS VENOVENOUS HEMOFILTRATION IN A LIVER TRANSPLANT PATIENT.
J. Mol. Med. 1995; 73 (3): 145–147.
PubMed

15.       Schmoldt, A., Sagowski, C., Iwersen, S., and Schulz, M.:
HEMMUNG DER ADH-AKTIVITÄT DES MAGENS DURCH H₂-REZEPTORENBLOCKER
[Inhibition of gastric alcohol dehydrogenase activity by histamine H₂-receptor antagonists].
Rechtsmedizin. 1995; 5: 73–77.

16.       Fox, J.M., with contribution of Menges, K., Coper, H., Doenicke, A., Ferner, U.J., Gaertner, H.J., Hoffmeister, F., Janke, W., Janzen, R.W.C., Kanowski, S., Kreiskott, H., Müller-Oerlinghausen, B., Netter, P., Oelschläger, H., Poser, W., Radke, J., Rüther, E. and Schulz, M.:
KOMBINATIONSARZNEIMITTEL AUS PARACETAMOL PLUS ACETYLSALICYLSÄURE: NUTZEN UND RISIKEN
[Fixed-dosed combinations of paracetamol(acetaminophen) and aspirin: benefits and risks].
Schmerz 1995; 9: 273–285.

17.       Scholz, J., Steinfath, M. and Schulz, M.:
CLINICAL PHARMACOKINETICS OF ALFENTANIL, FENTANYL, AND SUFENTANIL:
AN UPDATE.
Clin. Pharmacokinet. 1996; 31 (4): 275–292.
PubMed

18.       Schulz, M. and Schmoldt, A.:
THERAPEUTIC AND TOXIC BLOOD CONCENTRATIONS OF MORE THAN 500 DRUGS.
Pharmazie. 1997; 52 (12): 895–911.
PubMed

19.       Iwersen-Bergmann, S., Schmoldt, A., Püschel, K. and Schulz, M.:
VERGIFTUNGS- UND TODESFÄLLE DURCH SUBSTITUTIONSMITTEL IM UMFELD VON SUBSTITUIERTEN DROGENKONSUMENTEN.
Rechtsmedizin. 1999; 9 (3): 90–93.
Abstract

20.       Stein, S., Schmoldt, A. and Schulz, M.:
FATAL INTOXICATION WITH MELPERONE.
Forensic Sci. Int. 2000; 113 (1-3): 409–413.
PubMed

21.       Seibt, K., Schulz, M. and Hensel, F.J.:
MEINUNGEN UND EINSTELLUNGEN ZUM THEMA IMPFEN BEI NIEDERGELASSENEN ÄRZTEN, OFFIZINAPOTHEKERN UND IHREM PERSONAL SOWIE AKTUELLER IMPFSTATUS DIESER GRUPPEN
[Opinions and attitudes on the topic of vaccination of established physicians, pharmacists and their personnel and current vaccination status of these groups].
Gesundheitswesen. 2000; 62 (7): 376–382.
PubMed

22.       Schulz, M., Schmoldt, A., Donn, F. and Becker, H.:
LACK OF METHEMOGLOBINEMIA WITH FLUTAMIDE.
Ann. Pharmacother. 2001; 35 (1): 21–25.
PubMed

23.       Brockmeyer, R., Steindl, L., Behrens, I., Gnekow, S., Verheyen, F. and Schulz, M.:
Testing of the readability of package inserts at a community pharmacy.
Pharm. Ind. 2001; 63 (2): 114–119.

24.       Schulz, M., Verheyen, F., Mühlig, S., Müller, J.M., Mühlbauer, K., Knop-Schneickert, E., Petermann, F. and Bergmann, K.-C.:
PHARMACEUTICAL CARE SERVICES FOR ASTHMA PATIENTS. A CONTROLLED INTERVENTION STUDY.
J. Clin. Pharmacol. 2001; 41 (6): 668–676.
PubMed

25.       Azodi, K., Himstedt, S., Hinrichs, A., Krüger, M., Schrader, S. and Schulz, M.:
TESTING OF THE READABILITY OF PACKAGE LEAFLETS AS AN INITIAL STEP UNDER THE PHARMACEUTICAL CARE
INITIATIVE TOWARDS INCREASING THE SAFETY OF MEDICINAL PRODUTCS.
Pharm. Ind. 2002; 64 (11): 1119–1125.

26.       Hauner, H., Maxion-Bergemann, S., Müller, E., Schulz, M., Huppertz, E. and Bergemann, R.:
DMP DIABETES MELLITUS: SIMULATION DER BEHANDLUNGSERGEBNISSE VERSCHIEDENER LEITLINIEN.
Ein neues Diabetes mellitus Modell (DMM).
[Disease management program (DMP) diabetes mellitus: simulation of therapeutic results of different guidelines.
A new diabetes mellitus model (DMM)].
Dtsch. Med. Wochenschr. 2003; 128 (21): 1167–1172.
PubMed

27.       Schulz, M. and Schmoldt, A.:
THERAPEUTIC AND TOXIC BLOOD CONCENTRATIONS OF MORE THAN 800 DRUGS AND OTHER XENOBIOTICS.
Pharmazie. 2003; 58 (7): 447–474.
PubMed

28.       Van Mil, J.W.F., Schulz, M. and Tromp, Th.F.J.:
PHARMACEUTICAL CARE, EUROPEAN DEVELOPMENTS IN CONCEPTS, IMPLEMENTATION, TEACHING, AND
RESEARCH: A REVIEW.
Pharm. World Sci. 2004; 26 (6): 303–311.
PubMed 

29.       Berger, K, Eickhoff, C. and Schulz, M.:
Counselling quality in community pharmacies: 
Implementation of the pseudo customer methodology in Germany.
J. Clin. Pharm. Ther. 2005; 30 (1): 45–57.
PubMed

30.       Mangiapane, S., Schulz, M., Mühlig, S., Ihle, P., Schubert, I. and Waldmann, H.-C.:
COMMUNITY PHARMACY-BASED PHARMACEUTICAL CARE FOR ASTHMA PATIENTS.
Ann. Pharmacother. 2005; 39 (11): 1817–1822.
PubMed 

31.       Eickhoff, C. and Schulz, M.:
PHARMACEUTICAL CARE IN COMMUNITY PHARMACIES: PRACTICE AND RESEARCH IN GERMANY.
Ann. Pharmacother. 2006; 40 (4): 729–735.
PubMed

32.       Schulz, M., Graefe, T., Stuby, K., Andresen, H., Kupfermann, N. and Schmoldt, A.:
Case report: Acute unintentional carbachol intoxication.
Critical Care. 2006; 10: R84.
Full text

33.       Schulz, M., Hämmerlein, A., Hinkel, U., Weis, G. and Gillissen, A.:
SAFETY AND USAGE PATTERN OF AN OVER-THE-COUNTER AMBROXOL COUGH SYRUP:
A COMMUNITY PHARMACY-BASED COHORT STUDY.
Int. J. Clin. Pharmacol. Ther. 2006; 44 (9): 409–421.
PubMed

34.       Müller, U., Hämmerlein, A., Casper, A. and Schulz, M.:
EVALUATION DER DURCHFÜHRUNG VON GLUKOSESELBSTKONTROLLEN IN APOTHEKEN (EDGAr).
Diabetes Stoffw. Herz 2006; 15 (4): 9–17.
COMMUNITY PHARMACY-BASED INTERVENTION TO IMPROVE SELF-MONITORING OF BLOOD GLUCOSE IN
TYPE 2 DIABETIC PATIENTS.
Pharmacy Practice (Granada). 2006; 4 (4): 195–203.
Full text

35.       Schuessel, K. and Schulz, M.:
PRESCRIBING OF COX-2-INHIBITORS IN GERMANY AFTER SAFETY WARNINGS AND MARKET WITHDRAWALS.
Pharmazie. 2006; 61 (10): 878–886.
PubMed

36.       Van Mil, J.W.F. and Schulz, M.:
A review of Pharmaceutical Care in Community Pharmacy in Europe.
Harvard Health Policy Review. 2006; 7 (1): 155–168.
Full text

37.       Gerdemann, A., Griese, N. and Schulz, M.:
PHARMACY INTERNS ON THE WARD – A PILOT STUDY.
Pharm. World Sci. 2007; 29 (1): 34–38.
PubMed

38.       Rajska-Neumann, A., Wieczorowska-Tobis, K., Schulz, M., Breborowicz, A., Grzeskowiak, E. and Oreopoulos D.G.:
Duplicate use of angiotensin-converting enzyme (ACE) inhibitors in a community-dwelling
elderly population in Poland.
Arch. Gerontol. Geriatr. 2007; 44 (Suppl. 1): 295–301.
PubMed

39.       Bertsche, T., Hämmerlein, A. and Schulz, M.:
GERMAN NATIONAL DRUG INFORMATION SERVICE: USER SATISFACTION AND POTENTIAL POSITIVE PATIENT OUTCOMES.
Pharm. World. Sci. 2007; 29 (3): 167–172.
PubMed

40.       Hämmerlein, A., Griese, N., and Schulz, M.:
Survey of Drug-related Problems Identified by Community Pharmacies.
Ann. Pharmacother. 2007; 41 (11): 1825–1832.
PubMed   

41.       Schüssel, K., Quinzler, R., Czeche, S. and Schulz, M.:
AKTUELLE VEORDNUNGEN VON COX-2-HEMMERN IN DEUTSCHLAND
[Contemporary precriptions of COX-2 inhibitors in Germany].
Internist. Praxis. 2008; 48 (4): 837–850.

42.       Hämmerlein, A. and Schulz, M.:
Co-authors of the German National Disease Management Guideline (Nationale VersorgungsLeitlinie (NVL)) ASTHMA, 2^nd ed. 2009.
Eds.: Bundesärztekammer (BÄK), Kassenärztliche Bundesvereinigung (KBV), Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF).
Revision in: Dtsch. Ärztebl. 2011; 108 (11): A-596 / B-484 / C-484.
Guideline

43.       Hämmerlein, A., Müller, U. and Schulz, M.:
VERSORGUNGSMANAGEMENT FÜR MENSCHEN MIT ASTHMA – EINBINDUNG DER APOTHEKER
[Involving pharmacists in the management of asthma patients].
Z. Evid. Fortbild. Qual. Gesundh. wesen. 2010; 104 (2): 92–98.

44.       Hämmerlein, A., Müller, U. and Schulz M.:
Pharmacist-led intervention study to improve inhalation technique in asthma and COPD patients.
J. Eval. Clin. Pract. 2011; 17 (1): 61–70.
PubMed

45.       Krüger, M., Griese, N. and Schulz, M.:
Medikationsmanagement für Menschen mit Diabetes.
[Home medication review for patients with diabetes].
Diabetes Stoffw. Herz 2011; 20 (4): 219–226.
Abstract

46.       Hohmann, C., Eickhoff, C., Kämmerer, W. and Schulz, M.:
Compliance with antithrombotic guidelines in surgery patients in German hospitals:
A multicenter study involving pharmacy interns.
Clin. Appl. Thromb. Hemost. 2012; 18 (3): 299–304.
PubMed

47.       Ude, M., Schüssel. K., Quinzler, R., Leuner, K., Müller, W.E. and Schulz, M.:
Generic switch after ramipril patent expiry is not associated with decreased pharmacy refill compliance: a retrospective Study using the DAPI database.
J. Hypertens. 2011; 29 (9): 1837–1845. 
PubMed

48.       Hohmann, C. Eickhoff, C., Klotz, J.M., Schulz, M. and Radziwill, R.:
DEVELOPMENT OF A CLASSIFICATION SYSTEM FOR DRUG-RELATED PROBLEMS IN THE HOSPITAL SETTING (APS-Doc)
AND ASSESSMENT OF THE INTER-RATER RELIABILITY.
J. Clin. Pharm. Ther. 2012; 37 (3): 276–281.
PubMed

49.       Laufs, U., Böhm, M., Kroemer, H.K., Schüssel, K., Griese, N. and Schulz, M.:
Strategien zur Verbesserung der Einnahmetreue von Medikamenten
[Strategies to improve medication adherence].
Dtsch. Med. Wochenschr. 2011; 136 (31-32): 1616–1621.
PubMed

50.       Quinzler, R., Ude, M., Franzmann, A., Feldt, S., Schüssel, K., Leuner, K., Müller,
W.E., Dippel.F.-W. and Schulz, M.:
Treatment duration (persistence) of basal insulin supported oral therapy (BOT) in type 2 diabetic patients: comparison of insulin glargine with NPH insulin.
Int. J. Clin. Pharmacol. Ther. 2012; 50 (1): 24–32.
PubMed

51.       Eickhoff, C., Hämmerlein, A., Griese, N. and Schulz, M.:
Nature and frequency of drug-related problems in self-medicatioN (OVER-THE-COUNTER DRUGS) in
daily community pharmacy practice in Germany.
Pharmacoepidemiol. Drug Saf. 2012; 21 (3); 254-260. 
PubMed

52.       Hohmann, C., Eickhoff, C., Radziwill, R. and Schulz, M.:
Adherence to guidelines for antibiotic prophylaxis in surgery patients in German hospitals: A multicenter evaluation involving pharmacy interns.
Infection. 2012; 40 (2): 131–137.
PubMed

53.       Feldt, S., Schüssel, K., Quinzler, R., Franzmann, A., Czeche, S., Ludwig, W.-D. and Schulz, M.:
INCIDENCE OF THYROID HORMONE THERAPY IN PATIENTS TREATED WITH SUNITINIB OR SORAFENIB: A COHORT STUDY.
Eur. J. Cancer 2012; 48 (7): 974-981.
PubMed

54.       Schulz, M., Iwersen-Bergmann, S., Andresen, H. and Schmoldt, A.:
THERAPEUTIC AND TOXIC BLOOD CONCENTRATIONS OF NEARLY 1,000 DRUGS AND OTHER XENOBIOTICS.
Critical Care. 2012; 16: R136. [>29k Article Accesses].

            Full text incl. suppl. material  Additional file 1 

55.       Ude, M., Leuner, K., Schüssel, K., Schulz, M. and Müller, W.E.:
ADHERENCE TO ANTIHYPERTENSIVES: FEASIBILITY OF TWO SELF-REPORT INSTRUMENTS TO INVESTIGATE MEDICATION-TAKING BEHAVIOUR IN GERMAN COMMUNITY PHARMACIES.
Int. J. Pharm. Pract. 2013; 21 (3): 169-177.
PubMed

56.       Nicolas, A., Eickhoff, C., Griese, N. and Schulz, M.:
drug-related problems in prescribed medicines IN GermanY at the time OF dispensING.
Int. J. Clin. Pharm. 2013; 35 (3): 476-482. 
PubMed

57.       Czeche, S., Schüssel, K., Franzmann, A., Burkart, M. and Schulz, M.:
DOSAGE STRENGTH IS ASSOCIATED WITH MEDICATION PERSISTENCE WITH GINGKO BILOBA DRUG PRODUCTS.
BMC Complement. Altern. Med. 2013; 13 (1): 278. 
Full text    PDF

58.       Saverno, K., Gothe, H., Schüssel, K., Biskupiak, J.E., Schulz, M., Siebert, U. and Brixner, D.:
Consideration of International Generic Distribution Policies on Patient Outcomes in the
United States and Germany.
Pharmazie. 2014; 69 (3): 238-240. 
PubMed

59.       Schorr, S.G., Eickhoff, C., Feldt, S., Hohmann, C. and Schulz, M.:
EXPLORING THE potential impact of hospital ward-based pharmacy interns on drug safety.
Pharmazie. 2014; 69 (4): 316-320.
PubMed

60.       Ewen, S., Baumgarten, T., Rettig-Ewen, V., Mahfoud, F., Griese-Mammen, N., Schulz, M., Böhm, M. and Laufs, U.:
Analyses of drugs stored at home by elderly patients with chronic heart failure.
Clin. Res. Cardiol. 2015; 104 (4): 320-327.
PubMed

61.       Fikenzer, K., Knoll, A., Fischer, D., Schulz, M., Böhm, M. and Laufs, U.:
Chronische Herzinsuffizienz: Teufelskreis aus geringer Einnahmetreue von Medikamenten und
kardialer Dekompensation.
[Poor medication adherence and worsening heart failure - a vicious circle].
Dtsch. Med. Wochenschr. 2014; 139 (47): 2390-2394.
PubMed

62.       Krueger, K., Botermann, L., Schorr, S.G., Griese-Mammen, N., Laufs, U. and Schulz, M.:
Age-related medication adherence in patients with chronic heart failure: a systematic literature review.
Int. J. Cardiol. 2015; 184: 728-735.
PubMed

63.       Schulz, M., Meins, J., Diemert, S., Zagermann-Muncke, P., Goebel, R., Schrenk, D., Schubert-Zsilavecz, M. and Abdel-Tawab, M.:
Detection of pyrrolizidine alkaloids in German licensed herbal medicinal teas.
Phytomedicine. 2015; 22 (6): 648-656.
PubMed      ScienceDirect

64.       Hansen, K., Schüssel, K., Kieble, M., Werning, J., Schulz, M., Friis, R., Pöhlau, D., Schmitz, N. and Kugler, J.:
Adherence to disease modifying drugs among patients with multiple sclerosis in Germany:
A retrospective cohort study.
PLoS One. 2015; 10 (7): e0133279. 
Full text

65.       van Mil, J.W.F., Westerlund, T., Brown, L., Chen, T.F., Henman, M., Hersberger, K.,  McElnay, J. and Schulz, M.:
Medical care and Drug-related problems: Do doctors and pharmacists speak the same language?
Int. J. Clin. Pharm. 2016; 38 (2): 191–194, erratum 195. 
PubMed     Erratum

66.       Botermann, L., Krueger, K., Eickhoff, C., Kloft, C. and Schulz, M.:
PATIENT’S HANDLING OF A STANDARDIZED MEDICATION PLAN: A PILOT STUDY AND METHOD DEVELOPMENT.
Patient Prefer. Adherence. 2016; 10: 621–630. 
Full text 

67.       Botermann, L., Monzel, K., Krueger, K., Eickhoff, C., Wachter, A., Kloft, C., Laufs, U. and Schulz, M.:
EVALUATING  PATIENTS’ COMPREHENSIBILITY OF A STANDARDIZED MEDICATION PLAN.
Eur. J. Clin. Pharmacol. 2016; 72 (10): 1229–1237. 
PubMed     EJCP

68.       Schulz, M., Krueger, K., Schuessel, K., Friedland, K., Laufs, U., Müller, W.E. and Ude, M.:
MEDICATION ADHERENCE AND Persistence according to DIFFERENT antihypertensive drug classES:
A RETROSPECTIVE  cohort STUDY of 255,500 patients.
Int. J. Cardiol. 2016; 220: 668–676. 
PubMed     IJC     Full text 

69.       Ganso, M., Goebel, R., Melhorn, S., Schrenk, D. and Schulz, M.:
Lipidpneumonie durch LIPID-haltige Nasensprays und -tropfen
[Lipoid pneumonia associated with lipid-containing nasal sprays and nose drops].
Laryngo-Rhino-Otol. 2016; 95 (8): 534–539. 
PubMed     

70.       Gradl, G., Krieg, E.-M. and Schulz, M.: 
EVALUATION OF PHARMACEUTICAL CONCERNS IN GERMANY: FREQUENCY AND POTENTIAL REASONS.
Pharmacy Practice (Granada). 2016; 14 (3): 786. 
PubMed     Full text     Suppl. material  

71.       Schulz, M., Goebel, R., Schumann, C. and Zagermann-Muncke, P.: 
Non-prescription dispensing of emergency oral contraceptives: Recommendations from the
German Federal Chamber of Pharmacists [Bundesapothekerkammer].
Pharmacy Practice (Granada). 2016; 14 (3): 828. 
PubMed     Full text 

72.        Custodis, F., Rohlehr, F., Wachter, A., Böhm, M., Schulz, M. and Laufs, U.:
Medication knowledge of patients hospitalized for heart failure at admission and after discharge.
Patient Prefer. Adherence. 2016; 10: 2333–2339. 
PubMed 

73.        Krueger, K., Griese-Mammen, N., Schubert, I., Kieble, M., Botermann, L., Laufs, U., Kloft, C. and Schulz, M.: 
IN SEARCH OF A STANDARD WHEN ANALYZING MEDICATION ADHERENCE IN PATIENTS WITH HEART FAILURE USING
CLAIMS DATA: A SYSTEMATIC REVIEW.
Heart Fail. Rev. 2018; 23 (1): 63–71.   

            PubMed         

74.      Botermann, L., Wachter, A., Monzel, K., Krueger, K., Ewen, S., Mahfoud, F., Griese-Mammen, N., Schulz, M. and Laufs, U.: 
             DO PATIENTS WITH DIABETES TYPE 2 OR CHRONIC HEART FAILURE UNDERSTAND A MEDICATION PLAN?
             Pharmazie. 2017; 72 (12): 764–768. 
             PubMed  

75.        Felberg, M., Reckers, K., Schulz, M. and Scherneck, S.: 
             DER DIABETOLOGISCH QUALIFIZIERTE APOTHEKER DDG. EVALUATION EINER PRAXISORIENTIERTEN INTENSIV-FORTBILDUNG
             [Community pharmacist care of patients with diabetes: opportunities and limitations].
             Med. Monatsschr. Pharm. 2017; 40 (11): 496–501. 

76.        Weißenborn, M., Schulz, M., Kraft, M., Haefeli, W.E. and Seidling, H.M.: 
            POTENTIELLE ERFOLGSINDIKATOREN FÜR DIE DURCHFÜHRUNG VON PROJEKTEN ZUR ARZT-
             APOTHEKER-ZUSAMMENARBEIT – EINE SYSTEMATISCHE ÜBERSICHT  
             [Potential benchmarks for successful interdisciplinary collaboration projects in Germany – A systematic review]. 
             Gesundheitswesen. 2019; 81 (12): 1057–1068. Epub June 21, 2018. 

             PubMed  

77.        Laufs, U., Griese-Mammen, N., Krueger, K., Wachter, A., Anker, S.D., Koehler, F., Rettig-Ewen, V.,
             Botermann, L., Strauch, D., Trenk, D., Böhm, M. and Schulz, M.: 
             PHARMACY-BASED INTERDISCIPLINARY PROGRAM FOR PATIENTS WITH CHRONIC HEART FAILURE (PHARM-CHF): RATIONALE
             AND DESIGN OF A RANDOMIZED CONTROLLED TRIAL AND RESULTS OF THE PILOT STUDY.
             Eur. J. Heart Fail. 2018; 20 (9): 1350–1359. 

             PubMed 

78.       Dormann, H., Maas, R., Eickhoff, C., Müller, U., Schulz, M., Brell, D. and Thürmann, P.:
ERPROBUNG DES BUNDESEINHEITLICHEN MedikationsplanS IN DER PRAXIS: Die Pilotprojekte MetropolMediplan 2016, Modellregion Erfurt und PRIMA
[Testing the standardized medication plan: the pilot projects MetropolMediplan 2016, model region Erfurt and PRIMA].
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2018; 61 (9): 1093–1102.  

             Full text  

79.        Müller, U., Schulz, M. and Mätzler, M.:
Elektronisch unterstützte Kooperation ambulant tätiger Ärzte und Apotheker zur Verbesserung der Arzneimitteltherapiesicherheit. Die Arzneimittelinitiative Sachsen-Thüringen (ARMIN)
[Electronically supported co-operation of physicians and pharmacists to improve medication safety in the ambulatory setting. The “Arzneimittelinititative Sachsen-Thüringen” (ARMIN)].
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2018; 61 (9): 1119–1128.  

             Full text   

80.       Gradl, G., Teichert, M., Kieble, M., Werning, J. and Schulz, M.:
            COMPARING OUTPATIENT ORAL ANTIBIOTIC USE IN GERMANY AND THE NETHERLANDS FROM 2012 TO 2016.
            Pharmacoepidemiol. Drug Saf. 2018; 27 (12): 1344–1355.   

            Full text                   
81.       Said, A., Goebel, R., Ganso, M., Zagermann-Muncke, P. and Schulz, M.: 
            Drug shortages may compromise patient safety: results of a survey of the
            reference pharmacies of the Drug Commission of German Pharmacists.
            Health Policy. 2018; 122 (12):1302–1309. 
            PubMed  
82.       Katzman, J., Mahfoud, F., Böhm, M., Schulz, M. and Laufs, U.:
            Association of medication adherence and depression with control of LDL
            Cholesterol and blood pressure in patients with high cardiovascular risk.
            Patient Prefer. Adherence. 2019; 13: 9–19. 
            Full text  
83.       Ihle, P., Krueger, K., Schubert, I. Griese-Mammen, N., Parrau, N., Laufs, U. and Schulz, M.: 
            COMPARISON OF DIFFERENT STRATEGIES TO MEASURE MEDICATION ADHERENCE VIA CLAIMS
            DATA IN PATIENTS WITH CHRONIC HEART FAILURE. 
            Clin. Pharmacol. Ther. 2019; 106 (1): 211–218.  

            Full text  
84.       Breiholz, S., Griese-Mammen, N., Krueger, K., Schaefer, M. and Schulz, M.:
            Acceptance of a Medication Refill Reminder Service in GERMAN Community Pharmacy 
            Practice.
            Pharmazie. 2019; 74 (3): 186–190.
             PubMed  
85.       Eickhoff, C., Müller, U., Strunz, A.K., Seidling, H.M., Lampert, A., Felberg, M., Breiholz, S., Klintworth, D. and Schulz, M.: 
            Das Projekt PRIMA - Elektronische Erstellung und Aktualisierung von Medikationsplänen als gemeinsame Aufgabe von
            Ärzten und Apothekern 
            [The PRIMA project - electronically-supported physician-pharmacist co-operation to generate and update medication plans
            in Germany].  

            Dtsch. Med. Wochenschr. 2019; 144 (18): e114–e120.   
             Full text  
86.       Schulz, M., Griese-Mammen, N., Anker, S.D., Koehler, F., Ihle, P., Ruckes, C., Schumacher, P.M., Trenk, D., Böhm, M. and Laufs, U.:  
            PHARMACY-BASED INTERDISCIPLINARY INTERVENTION FOR PATIENTS WITH CHRONIC HEART
            FAILURE: RESULTS OF THE PHARM-CHF RANDOMIZED CONTROLLED TRIAL.
            Eur. J. Heart Fail. 2019; 21 (8): 1012–1021. 
            Full text   Suppl. Material 

87.       Hofmann, G. A., Gradl, G., Schulz, M., Haidinger, G., Tanew, A. and Weber, B.: 
            THE FREQUENCY OF PHOTOSENSITIZING DRUG DISPENSINGS IN AUSTRIA AND GERMANY: A
            CORRELATION WITH THEIR PHOTOSENSITIZING POTENTIAL BASED ON PUBLISHED LITERATURE.  
            J. Eur. Acad. Dermatol. Venereol. 2020; 34 (3): 589–600. 

            PubMed     Wiley   

88.       Said, A., Ganso, M., Freudewald, L. and Schulz, M.: 
            TRENDS IN DISPENSING ORAL EMERGENCY CONTRACEPTIVES AND SAFETY ISSUES: 
            A SURVEY OF GERMAN COMMUNITY PHARMACISTS. 
            Int. J. Clin. Pharm. 2019; 41 (6): 1499–1506.  
            IJCP   PDF   Suppl. Material   

89.       Schönfeld, T., Heineman, A., Schulz, M., Gradl, G., Andresen-Streichert, H., Müller, A. and  Iwersen-Bergmann, S.: 
            POST-MORTEM ANALYSIS OF PRESCRIPTION OPIOIDS - A FOLLOW-UP EXAMINATION BY LC-MS/MS
            WITH FOCUS ON FENTANYL. 
            Forensic Science International. 2019; 305: 109970. 
            Forensic Sci Int       PubMed   
90.       Schulz, M., Schmoldt, A., Andresen-Streichert, H. and Iwersen-Bergmann, S.:
            REVISITED: THERAPEUTIC AND TOXIC BLOOD CONCENTRATIONS OF MORE THAN 1,100 DRUGS AND OTHER XENOBIOTICS.
            Critical Care. 2020; 24 (1): 195. [15k Article Accesses as of 15 August 2024].
            PDF     Suppl File         
91.       Schulz, M., Griese-Mammen, N., Schumacher, P.M., Anker, S.D., Koehler, F., Ruckes, C., Rettig-Ewen, V., Wachter, R., Trenk, D.,
            Böhm, M. and Laufs, U.:  
            THE IMPACT OF PHARMACIST/PHYSICIAN CARE ON QUALITY OF LIFE IN ELDERLY HEART FAILURE PATIENTS:
            RESULTS OF THE PHARM-CHF RANDOMIZED CONTROLLED TRIAL.
            ESC Heart Failure. 2020; 7 (6): 3310–3319.   

            PDF     
92.       Garcia Cardenas, V., Rossing, C., Fernandez-Llimos, F., Schulz, M., Tsuyuki, R.T., Bugnon, O., Tonin, F. and Benrimoj, S.I.: 
            PHARMACY PRACTICE RESEARCH – A CALL TO ACTION.  
            Research in Social and Administrative Pharmacy. 2020; 16 (11): 1602–1608.   
            RSAP   PubMed   
93.       Mahfoud, F., Kieble, M., Enners, S., Werning, J., Laufs, U., Millenaar, D., Böhm, M., Kintscher, U. and Schulz, M.:
            ROTE-HAND-BRIEF ZU HYDROCHLOROTHIAZID UND VERORDNUNG VON ANTIHYPERTENSIVA
            [„Dear Doctor“ warning letter (Rote-Hand-Brief) on hydrochlorothiazide and its impact on antihypertensive prescription].
            Deutsches Ärzteblatt International. 2020; 117 (41): 687–688. 
             PDF   
94.      Schulz, M., Griese-Mammen, N., Schumacher, P.M., Strauch, D., Freudewald, L., Said, A., Tsuyuki, R.T., Laufs, U., Kintscher, U.,
           Böhm, M. and Mahfoud, F.: 

           Development and Implementation of Blood Pressure Screening and Referral Guidelines for German
           Community Pharmacists.

           Journal of Clinical Hypertension. 2020; 22 (10): 1807–1816.   
           PDF 
95.      Rudolph, U., Enners, S., Kieble, M., Mahfoud, F., Böhm, M., Laufs, U. and Schulz, M.: 

           IMPACT of Angiotensin Receptor Blocker Product Recalls ON ANTIHYPERTENSIVE PRESCRIBING in Germany.
           Journal of Human Hypertension. 2021; 35: 903–911 [DOI: 10.1038/s41371-020-00425-z]. 

           PDF   
96.     Moorkens, E., Barcina, T., Vulto, A.G., Schulz, M., Gradl, G., Enners, S., Selke, G., Huys, I. and Simoens, S.:
          Learnings from Regional Market Dynamics of Originator and Biosimilar Infliximab and
          Etanercept in Germany.
          Pharmaceuticals. 2020; 13 (10): 324.    
          PDF  
97.     Said, A., Freudewald, L., Parrau, N., Ganso, M. and Schulz, M.: 
          Pharmacists’ perception of educational material TO IMPROVE PATIENT SAFETY: A CROSS-SECTIONAL
          sTuDy on practices and awareness IN GERMANY.  
          Medicine. 2021; 100 (11): e25144. 
          PDF   
98.     Rüsenberg, R., Baumgarten, A., Mauss, S., Gradl, G., Schulz, M., Bartmeyer, B., Kollan, C. and Schmidt, D.: 
          WIE WIRKEN GENERIKAQUOTEN? EINE ANALYSE AM BEISPIEL HIV
          [How do generic quotas work? An analysis using HIV infection as an e example]. 
          Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2021; 64 (5): 625–634.   

          PDF   

99.    Gradl, G., Werning, J., Enners, S., Kieble, M. and Schulz, M.: 
         Quality appraisal of AMBULATORY oral cephalosporin and fluoroquinolone use in
         the 16 German federal states from 2014–2019. 
         Antibiotics. 2021; 10 (7): 831. 
        PDF   

100.  Schumacher, P.M., Becker, N., Griese-Mammen, N., Tsuyuki, R.T., Koshman, S.K., McDonald, M.A., Bouvy, M.,
         Rutten, F.H., Laufs, U., Böhm, M. and Schulz, M.: 
         THE EVIDENCE FOR PHARMACIST CARE IN OUTPATIENTS WITH HEART FAILURE: A SYSTEMATIC REVIEW AND META-ANALYSIS.  
         ESC Heart Failure. 2021; 8: 3566–3576 [DOI: 10.1002/ehf2.13508]. 

         PDF  
101.  Enners, S., Gradl, G., Kieble, M., Böhm, M., Laufs, U. and Schulz, M.: 

         UTILIZATION OF DRUGS WITH REPORTS ON POTENTIAL EFFICACY OR HARM ON COVID-19 BEFORE, DURING, AND AFTER
         THE FIRST PANDEMIC WAVE.
         Pharmacoepidemiology and Drug Safety. 2021; 30 (11): 1493–1503  [DOI: 10.1002/pds.5324].  

         PDF     
102.  Schumacher, P.M., Griese-Mammen, N., Schneider, J., Laufs, U. and Schulz, M.: 
         INTERDISCIPLINARY PHYSICIAN-PHARMACIST MEDICATION REVIEW FOR OUTPATIENTS WITH HEART FAILURE:
         A SUBANALYSIS OF THE PHARM-CHF RANDOMIZED CONTROLLED TRIAL. 
         Frontiers in Pharmacology. 2021; 12: 712490 [DOI: 10.3389/fphar.2021.712490].
         PDF     
103.  Arnet, I., Verbeek, M., Almarsdóttir, A.B., Barbier, L., Clifford, R., Eickhoff, C., Hersberger, K., Huys, I., Lee, K.,
        Saramunee, K., Schulz, M., Zgarrick, D., Sarnola, K.: 

        Community pharmacists’ preparedness for substituting biologics and dispensing
        biosimilars – lessons learned from a multinational survey. 
        Exploratory Research in Clinical and Social Pharmacy 2021; 4 (Dec.): 100084 [DOI: 10.1016/j.rcsop.2021.100084].
104.  Eickhoff, C., Müller, U., Seidling, H.M., Lampert, A., Botermann, L., Strunz, A.K. and Schulz, M.: 

         PATIENTS’ PERCEPTION ON GENERATING MEDICATION PLANS IN AN INTERPROFESSIONAL MEDICATION
         MANAGEMENT PROGRAM: A MIXED-METHODS STUDY.
         Journal of Interprofessional Care. 2022; 36 (5): 770–775 [DOI: 10.1080/13561820.2021.1994935].  

         PDF 
105. Mahfoud, F., Kieble, M., Enners, S., Kintscher, U., Laufs, U., Böhm M. and Schulz, M.: 
        Use of fixed-dose combination antihypertensives in Germany between 2016 AND 2020:
        an example of guideline inertia. 
        Clinical Research in Cardiology. 2023; 112 (2): 197–202 [DOI: 10.1007/s00392-022-01993-5].  

        PDF   
106. Mikus, G., Foerster, K.I., Terstegen, T., Vogt, C., Said, A., Schulz, M. and Haefeli, W.E.: 
        Oral drugs against COVID-19 – management of drug interactions with the use of nirmatrelvir/ritonavir 
        [Orale Pharmakotherapie bei COVID-19 – Wechselwirkungsmanagement beim Einsatz von Nirmatrelvir/Ritonavir].  
        Deutsches Arzteblatt International. 2022; 119 (15): 263–269 [DOI: 10.3238/arztebl.m2022.0152]. 
        PDF    
107. Katzmann, J.L., Kieble, M., Enners, S., Böhm, M., Mahfoud, F., Laufs, U. and Schulz, M.: 

        TRENDS IN EZETIMIBE PRESCRIPTIONS AS MONOTHERAPY OR FIXED-DOSE COMBINATION IN
        GERMANY 2012–2021. 

        Frontiers in Cardiovascular Medicine. 2022; 9: 912785 [DOI: 10.3389/fcvm.2022.912785].

108. Koehler, F., Störk, S. and Schulz, M.: 
        telemonitoring of heart failure patients is reimbursed in germany – Challenges of
        Real world implementation remain (Letter). 
        European Heart Journal – Digital Health. 2022; 3 (2): 121–122 [DOI: 10.1093/ehjdh/ztac017].. 
        PDF   
109. Abdin, A., Schulz, M., Riemer, U., Hadëri, B., Wachter, R, Laufs, U., Bauersachs, J., Kindermann, I., Vukadinović, D. and Böhm, M.:
        Sacubitril/valsartan in heart failure: Efficacy and safety in and outside clinical trials. 
        ESC Heart Failure. 2022; 9 (6): 3737–3750 [DOI: 10.1002/ehf2.14097].  

         PDF    
110. Moecker, R., Weissenborn, M., Klingenberg, A., Wirbka, L., Fuchs, A., Eickhoff, C., Mueller, U., Schulz, M., Kaufmann-Kolle, P.,
        ARMIN Study Group, Haefeli, W.E. and Seidling, H.M.: 
        Task sharing in an interprofessional medication management program – a survey of general
        practitioners and community pharmacists. 
        BMC Health Services Research. 2022; 22 (1): 1005 [DOI: 10.1186/s12913-022-08378-4].  
         PDF   
111. Schulz, M., Griese-Mammen, N. and Müller, U.:  
        Clinical pharmacy services are reimbursed in germany – Challenges of real world
        implementation remain (Commentary). 
        International Journal of Clinical Pharmacy. 2023; 45 (1): 245–249 [DOI: 10.1007/s11096-022-01492-7].   

        PDF   
112. Gradl, G., Kieble, M., Nagaba, J. and Schulz, M.: 
        Assessment of the prescriptions of systemic antibiotics in primary dental care in Germany
        from 2017 to 2021: A Longitudinal Drug Utilization StuDy. 
        Antibiotics. 2022; 11 (12): 1723 [DOI: 10.3390/antibiotics11121723]. 
        PDF    

113. Gehrke-Beck, S., Petersen, M. Herrmann, W.J., Zimmermann, N., Daub, E., Seeger, J., Schulz, J., Czimmeck, C., Lauterbach, N.,
        Peters, H., Kloft, C., Schulz, M., Siebenbrodt, I. and Behrend, R.:  
        DEVELOPMENT OF A PROJECT FOR INTERPROFESSIONAL COLLABORATION BETWEEN MEDICAL AND PHARMACY
        STUDENTS TO IMPROVE MEDICATION SAFETY IN POLYPHARMACY (PILLE). 
        [Entwicklung eines Lehrprojekts zur interprofessionellen Zusammenarbeit von Medizin- und Pharmaziestudierenden zur
        Verbesserung der Arzneimitteltherapiesicherheit bei Polypharmazie (PILLE)]. 
        GMS Journal for Medical Education. 2023; 40 (1): Doc3 [DOI: 10.3205/zma001585].  
        PDF   
114.  Bertsche, T., Alexa J. M., Eickhoff, C. and Schulz, M.: 
         Self-care AND SELF-MEDICATION as central componentS of healthcare in Germany – On the way to
         evidence-based pharmacy. 
         Exploratory Research in Clinical and Social Pharmacy. 2023; 9 (3): 100257 [DOI: 10.1016/j.rcsop.2023.100257].
         PDF 

115. Götzinger, F., Wilke, T., Hardtstock, F., Krieger, J., Maywald, U., Kunz, M., Lauder, L., Schulz, M., Mahfoud, F. and Böhm, M.: 
        ASSOCIATION OF HYDROCHLOROTHIAZIDE TREATMENT COMPARED TO ALTERNATIVE DIURETICS WITH OVERALL
        AND SKIN CANCER RISK: A PROPENSITY-MATCHED COHORT STUDY. 
        Journal of Hypertension. 2023; 41 (6): 926–933 [DOI: 10.1097/HJH.0000000000003414].  

        PubMed 
116. Enners, S., Gradl, G., Kieble, M., Iliescu, O., Freudewald, L., Said, A. and Schulz, M.: 
        Increased demand for pharmaceutical drugs containing potassium iodide in connection with
        the Russia-Ukraine conflict. 
        Pharmazie. 2023; 78 (1): 17–19 [DOI: 10.1691/ph.2023.2541].  
         PDF 
117. Schulz, M. and Laufs, U.:
        Not obtaining a medication the first time it is prescribed: primary non-adherence to
        cardiovascular pharmacotherapy. 
        Clinical Research in Cardiology. 2024; 113 (8): 1103–1116 [DOI: 10.1007/s00392-023-02230-3].  

         PDF  

118. Eickhoff, C., Müller, U., Thomas, S., Schmidt, C., Hartling, L.-S., Michael, S., Schulz, M. and Bertsche, T.: 
        patients’ USE OF A STANDARDIZED MEDICATION LIST – A mixed methods study. 
        Patient Preference and Adherence. 2023; 17: 2655–2666 [DOI: 10.2147/PPA.S427192].  
        PDF  
119. Kerwagen, F., Riemer, U., Wachter, R., von Haehling, S., Abdin, A., Böhm, M., Schulz, M. and Störk, S.: 

          impact of the COVID-19 pandemic ON IMPLEMENTATION of novel guideline-directed medical therapies for
          heart failure in germany: a nationwide retrospective analysis. 
        The Lancet Regional Health – Europe. 2023; 35: 100778 [DOI: 10.1016/j.lanepe.2023.100778].  
         PDF  

120. Arnet, I., Sahm, L.J., Gregório J., Tuula, A., Krueger, M., Wurmbach, V., Kreshnik, H., Schulz, M. and Eickhoff, C.: 
        Development and validation of the 15-STARS - a novel self-report PHARMACY-BASED
        questionnaire to screen for medication non-adherence. 
        Research in Social and Administrative Pharmacy. 2024; 20 (3): 308–320 [DOI: 10.1016/j.sapharm.2023.11.005].     

        PDF   

121. Kunz, M., Götzinger, F., Jacobs, C.M., Lauder, L., Ukena, C., Meyer, M.R., Laufs. U., Schulz, M., Böhm, M. and Mahfoud, F.:  
        THE HIDDEN Sodium IN EFFERVESCENT TABLETS of dietary supplementS and over-the-counter
        DRUGS – A comparative cross-sectional study. 
        BMJ Open. 2023; 13: e076302 [DOI: 10.1136/bmjopen-2023-076302].
        PDF 
122. Messner, K., Eickhoff, C., Schulz, M., Allemann, S. and Arnet, I.: 
        KNOWLEDGE AND ATTITUDES OF GERMAN AND SWISS COMMUNITY PHARMACISTS TOWARDS BIOLOGICALS
        AND BIOSIMILARS  – A PROSPECTIVE SURVEY BEFOR AND AFTER THE COVID-19 PANDEMIC. 
        BMC Health Services Research. 2023; 23: 1432 [DOI: 10.1186/s12913-023-10475-x].
        PDF 
123. Rohr, B.S., Krohmer, E., Foerster, K.I., Burhenne, J., Schulz, M., Blank, A., Mikus, G., Haefeli, W.E.: 
        Time course of the interaction between oral short-term ritonavir therapy with three
        factor Xa inhibitors and the activity of CYP2D6, CYP2C19, and CYP3A4 in healthy volunteers. 
        Clinical Pharmacokinetics. 2024; 63 (4): 469–481 [DOI: 10.1007/s40262-024-01350-x].  

        PDF   
124. Arnet, I., Eickhoff, C., Sahm, L.J., Caloz, S., Mittag, M., Schulz, M. and Allemann, S.S.: 
        INCONCLUSIVENESS OF PSYCHOMETRIC TESTING OF MEDICATION ADHERENCE QUESTIONNAIRES. 
        European Journal of Clinical Pharmacology. 2024; 80 (8): 1189–1195 [DOI: 10.1007/s00228-024-03684-8].  

        PDF    
125. Götzinger, F., Kieble, M, Espinosa Daudí, A., Kunz, M., Lauder, L., Böhm, M., Laufs, U., Mahfoud, F. and Schulz, M.: 
        USE OF FIXED-DOSE COMBINATIONS FOR CARDIOVASCULAR INDICATIONS FROM 2018 TO 2023: 
        A NATIONWIDE POPULATION-BASED STUDY. 
        Journal of Hypertension. 2024; 42 (10): 1720–1727: [DOI: 10.1097/HJH.0000000000003789].  

        Journal     PubMed   
126. Hilgarth, H., Gradl, G., Metzger, N., Dörje, F., Schulz, M., Wolf, C. and Seidling, H.M.; 
        für die ADKA-DPhG Arbeitsgruppe Entlassmanagement / Entlassrezepte (Collaborators): 
        EINSATZ VON EntlassrezeptEN. ein überblick AUS DEUTSCHLAND FÜR die jahre 2018 bis 2021 
        [The utilization of discharge prescriptions in Germany—an overview for the years 2018–2021]. 
        Deutsches Arzteblatt International. 2024; 121 (16): 539–540 [DOI: 10.3238/arztebl.m2024.0095].  
        PDF 
127. Greene, S.J., Böhm, M., Bozkurt, B., Butler, J., Cleland, J.G.F., Coats, A.J.S., Desai, N.R., Grobbee, D.E., Kelepouris, E., 
        Pinto, F., Rosano, G., Morin, I., Szecsödy, P., Fabien, S., Waechter, S., Crespo-Leiro, M.G., Hülsmann, M., Kempf, T., Pfister, O., 
        Pouleur, A.-C., Sauer, A.J., Saxena, M., Schulz, M., Volterrani, M., Anker, S.D. and Kosiborod, M.N.: 
        Cardiovascular and Renal Treatment in Heart Failure Patients with Hyperkalemia or High Risk 
        of Hyperkalemia: Rationale and Design of the CARE-HK in HF Registry. 
        Journal of Cardiac Failure. 2024; 30: [DOI: 10.1016/j.cardfail.2024.08.048]. Epub Sep 12, 2024. 
         PDF   
 

TALKS, (INVITED) LECTURES, AND PAPERS PRESENTED

Over 500 speeches, posters, and invited talks/lectures (full list).

  

TEXTBOOKS 

 

1991     K. von Werder and M. Schulz: Prevention and Therapy of Osteoporosis (in German).
Wissenschaftliche Verlagsgesellschaft, Stuttgart, Germany.

1992     R. Braun and M. Schulz: Guidance on Patient Counselling in Case of Self-Medication (in German).
            Govi Publishing Co., Eschborn, Germany.

1994     R. Braun and M. Schulz: Self-Treatment: Counselling at the Pharmacy (in German). 
             Govi Publishing Co., Eschborn, Germany; 1^st – 9^th Supplement, 1996 – 2010.

1999     S. Mangiapane, M. Schulz and F. Verheyen: Handbooks Pharmaceutical Care
            (Eds.: Schaefer, M. and M. Schulz), Volume 2: Asthma (in German).
            Govi Publishing Co., Eschborn, Germany. 4^th edition 2005.

2000     M. Schaefer and M. Schulz: Handbooks Pharmaceutical Care
            (Eds.: Schaefer, M. and M. Schulz), Volume 1: Principles (in German).
            Govi Publishing Co., Eschborn, Germany.

2003     H. Derendorf, M. Schulz and R. Wemhöner: Applied Pharmacology, 7^th edition (in German). 

            Deutscher Apotheker Verlag, Stuttgart, Germany.

2004     C. Eckert-Lill, S. Schmitz, and M. Schulz (eds.): Family Pharmacy (in German). 
            Govi Publishing Co., Eschborn, Germany. 

2021    Griese-Mammen, N., Müller, U., Said, A. and Schulz, M. (eds.): Drug substitution – how to? 
            A practical guide (in German). Govi Publishing Co., Eschborn, Germany. 
 

  

TEACHING EXPERIENCE

 

Freie Universität Berlin, Institute of Pharmacy, Adjunct Professor (2015 – present)
WS 2015/16 – present     1 SH      Pharmacoepidemiology and Pharmaco-Economics (lecture)

Goethe-University Frankfurt, School of Pharmacy, Adjunct Professor (2005 – 2017)

SS 2005 – WS 2016/17     1 SH      Pharmacotherapeutics (lecture): Respiratory System: Asthma & COPD, 
                                                       Cardiovascular System: Heart Failure & Hypertension

                                                       Pharmaceutical Care/Medicines Management (seminar): Basic Principles, Scientific Evaluation, Asthma

SS 2004                          4 hrs.        Pharmaceutical care: Depression (seminar)

WS 2004/05                   4 hrs.        Emergency contraception ("Morning After Pill")

SS 2005                           4 hrs.        Pharmaceutical care of cancer patients

WS 2005/06                   4 hrs.        Pharmaceutical care of HIV/AIDS patients

WS 2006/07                   4 hrs.        Histamine H₁ receptor antagonists as hypnotics

SS 2007                           4 hrs.        Histamine H₂ receptor antagonists

WS 2007/08                   4 hrs.        Obesity: Definition, classification, epidemiology, measurement, risk factors

SS 2008                           4 hrs.        Pharmaceutical care of patients with atopic dermatitis

WS 2008/09                   4 hrs.         Diseases of the respiratory tract: Pharmaceutical care

SS 2009                           4 hrs.        Headaches: Counseling in the pharmacy

SS 2010                           4 hrs.        Self-medication/OTC-Use: Analgesics and antipyretics

WS 2010/11                   4 hrs.        Demographic Change: Pharmaco-cconomic challenges

 
Goethe-University Frankfurt, School of Pharmacy, Invited Lecturer (2001 – 2005)

WS 2001/02 –                1 SH         Principles of Evidence-based medicine, Pharmacoepidemiology, 

SS 2004                                           Pharmaco-Economics, and Pharmaceutical Care (lecture)

WS 2004/05                   4 hrs.        Scientific evaluation of Pharmaceutical Care I and II (seminar)

 

University Hamburg, School of Medicine

WS 1986/87                   1 hr.          Colloquium Forensic Medicine (for students of law)

SS 1987                           1 hr.          Topics:

WS 1987/88                   1 hr.          Toxicology I: Exhibits, Accident - Suicide - Homicide, Assessment/Expert opinion

SS 1988                           1 hr.          Toxicology II: Analytics, Illegal drugs, Medicines, Pesticides

WS 1987/88                   4 hrs.        Course, Basic and Systematic Pharmacology and Toxicology (for medical students)

SS 1988                           4 hrs.        Course, Basic and Systematic Pharmacology and Toxicology (for medical students)

SS 1988                           1 hr.          Basic Toxicology (for food chemistry students)

 

University Marburg, School of Pharmacy

SS 1992                           2 hrs.        Seminar medicinal products: Analgesics

SS 1994                           2 hrs.        Seminar: Pharmaceutical care

WS 1995/96                   2 hrs.        Seminar medicinal products: Sedatives and hypnotics

WS 1999/00                   2 hrs.        Seminar medicinal products: Pharmaceutical care in Germany

WS 2000/01                   2 hrs.        Seminar medicinal products: Drug information

WS 2001/02                   2 hrs.        Seminar medicinal products: Drug information

 

University Saarbruecken, School of Pharmacy

SS 1999                           2 hrs.        Asthma: Diagnosis, therapy and problem-solving by pharmaceutical care (lecture)

Humboldt-University Berlin (Consumer Health Care Master Program) 

SS 2001                           4 hrs.        Patient counseling in OTC-medicines (lecture)

Mandatory Pharmacy Intern Education (§ 4 (4) pharmacist licensing regulation)

March 1990, Univ. Frankfurt:                        Patient counseling (1) drug side/adverse effects

March 1991, Univ. Frankfurt:                        Patient counseling (2) drug/drug-interactions

                                                                     Patient counseling (3) side-effects in pregnancy and pediatrics

September 1992 – August 1994                    Intoxications and antidotes

Univ. Marburg and Univ. Frankfurt

 

Schools of Nursing

1983/84                     Pharmacology/           Johanniter Hospital Geesthacht and
                                  Pharmacotherapy        Hospital Reinbek St. Adolf-Stift

1986/87; 1987/88      Pharmacology/           University-Hospital Eppendorf, Hamburg
                                  Pharmacotherapy       

1986/87                     Pharmacology/           University-Hospital Eppendorf, Hamburg,
                                  Pharmacotherapy        Intensive Care and Anesthesiology

 

PhD/MSc STUDENTS 

 

-       Miriam Ude, PhD, Goethe-University Frankfurt, Department of Pharmacology/Clinical Pharmacy, Germany 2011: Evaluation der Adhärenz, Compliance und Persistenz bei Patienten unter antihypertensiver Therapie [Evaluation of medication adherence, compliance, and persistence with antihypertensives].

 

-       Lea Botermann, PhD, Freie Universität Berlin, Department of Clinical Pharmacy, Germany 2016: Der Medikationsplan zur Verbesserung der Arzneimitteltherapiesicherheit in Deutschland: Analyse des Status quo und Evaluation der Verständlichkeit bei Patienten mit Polymedikation [Medication plan to improve medication safety in Germany: Analysis of status quo and evaluation of the comprehensibility by patients with polypharmacy].  

 -       Salka Enners, MSc Epi, Berlin School of Public Health/Charité – Universitätsmedizin Berlin, Germany 2021: Utilization of drugs with reports on potential efficacy or harm on COVID-19 before, during, and after the first pandemic wave.

 

 

EXTERNAL PhD/MSc/Dipl.-Pharm. EXAMINATIONS

 

-       Alison Roberts, PhD – University of Sydney, Department of Pharmacy Practice, Australia 2006: Practice change in community pharmacy: The implementation of cognitive services.

 

-       Alexandros Liakos, Dipl.-Pharm./MSc – University of Bonn, Department of Clinical Pharmacy, Germany 2008: Drug-related problems in diabetic patients.

 

-       Teresa Margarida Mealha Salgado, PhD – University of Lisbon, Faculty of Pharmacy, Department of Social Pharmacy, Portugal 2013: The role of pharmacists on outpatients undergoing hemodialysis.

 

-       Gudrun Vogel, PhD – University of Bonn, Department of Clinical Pharmacy, Germany 2013: Management von Arzneimittelinteraktionen in der öffentlichen Apotheke [Management of drug/drug-interactions in community pharmacy practice].

 

-       Eimear Bridget O’Dwyer, MSc –Trinity College Dublin, School of Pharmacy, Department of Pharmacy Practice, Ireland 2014: An evaluation of a medicines information service for palliative care.

 

-       Katrin Krueger, Dipl.-Pharm./MSc – University Halle-Wittenberg, Institute of Pharmacy, Germany 2017: Methoden zur Analyse von Sekundärdaten zur Bestimmung der Medikamenten-Adhärenz bei chronischer Herzinsuffizienz – eine systematische Übersicht [Analyzing medication adherence in patients with chronic heart failure – a systematic review].

 

-       Danny Brell, PhD – University Witten/Herdecke, Department of Medicine, Germany 2018: Erprobung eines Medikationsplanes in der Praxis hinsichtlich Akzeptanz und Praktikabilität – Modellregion Erfurt [Testing the feasibility of a medication plan in daily practice – model region Erfurt].

 

-       Paul Steinborn, DDS – Charité – Universitätsmedizin Berlin, Institute of Physiology, Germany, 2019: Analyse der schmerztherapeutischen Entlassungsmedikation an der Charité – Universitätsmedizin Berlin [Analysis of the analgesic discharge medication at Charité – Universitätsmedizin Berlin].

 

-       Sandra Prescher, Dr. rer. medic. – Charité – Universitätsmedizin Berlin, Center for Cardiovascular Telemedicine, Department of Cardiology and Angiology, Germany, 2020: Adhärenz zur telemedizinischen Mitbetreuung von Patienten mit chronischer Herzinsuffizienz – eine retrospektive Analyse der randomisierten, kontrollierten Studien TIM-HF und TIM-HF2 [Adherence to telemonitoring by patients with chronic heart failure – a retrospective analysis of TIM-HF and TIM-HF2]. 

-     Alaa Fakher, MSc Pharm. Sciences – Freie Universität Berlin/Charité – Universitätsmedizin Berlin, Berlin Brandenburg Center for Regenerative Therapy, Germany 2020: Impact of S100A8/A9 inhibitor paquinimod on S100A8/A9-induced cardiac inflammation and fibrosis: an in vitro evaluation. 

 

-     Raphael Michael Sell, Dr. rer. medic. – Charité – Universitätsmedizin Berlin, Germany 2024, oral examination: Optimising medication safety by use of pharmacy-based medication reviews: drug-related problems, risk factors and methods to resolution. 

 

 

REQUESTED ACADEMIC REFERENCES
 

-      School of Pharmacy, University of Manchester, UK, 2010: Promotion to Chair (Full Professor).  

-      Institute of Pharmacy, Leopold-Franzens-University Innsbruck, A, 2020: Full Professor Clinical Pharmacy.  

-    Faculty of Pharmacy, University of Kuwait, 2020: Promotion to Associate Professor.  

 

REQUESTED SCIENTIFIC EVALUATIONS

-       Netherlands Institute for Health Services Research (NIVEL). Utrecht, the Netherlands.   

-       Swiss National Science Foundation. Bern, Switzerland.  

 

 

LINKS

• ABDA - Federal Union of German Associations of Pharmacists, Berlin 
  
• Arzneimittelkommission der Deutschen Apotheker (AMK; Drug Commission of German Pharmacists), Berlin 
• Deutsches Arzneiprüfungsinstitut e.V. (DAPI), Berlin 
• Freie Universität Berlin, Institute of Pharmacy 
• Goethe-University Frankfurt, Department of Pharmacology  
• Google Scholar 
• LinkedIn 
• PHARM-CHF (RCT) 
  
• Publons / Web of Science 
• ResearchGate 
• Wikipedia  
• Xing